J&J said it was “assuming full responsibility” of the Emergent BioSolutions facility in Baltimore, adding that it will deliver 100M doses to the U.S. government by the end of May.
U.S. puts Johnson & Johnson in charge of plant that botched batch of COVID-19 vaccines
